In 2023, BIŌNTE received a 1.4 million Euro investment from Centro para el Desarrollo Tecnológico y la Innovación (CDTI). This grant is intended for technological and scientific investment that BIŌNTE will carry out in the coming years. The company will allocate this grant to research on mycotoxins, the development of anti-mycotoxin solutions, and the development of a comprehensive technical service to offer a complete plan against the challenge of mycotoxins in animal production.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.